A new target for antidepressant treatment: microglia mediated neuroinflammation

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1003068

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Depression is the leading cause of non-fatal disease burden in Australia. Unfortunately, current antidepressants do not provide adequate levels of relief and it is accepted that we need to develop more effective treatments. We have recently shown that a drug that reduces inflammation in the brain also reduces depression-like symptoms. This project aims to extend upon these extremely promising findings, in the hope of developing a new and more effective generation of antidepressants.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2014

Funding Scheme: Project Grants

Funding Amount: $359,601.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

animal model | antidepressants | depression | glial cells | mood disorders | neuroinflammation | psychological stress

Related Links